RxDoctor Payments Data

Timothy Skelton

Clinical Pathology/Laboratory Medicine · Burlington, MANPI 1114027257

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $63,676 of the $80,171 with a category attached, or 79.4%. 6 manufacturers reported payments, led by Arkray USA, Inc. at 56.5% of the total. Reporting peaked in 2019 at $50,627 and has fallen 99.6% since, to $221 in 2025. Among clinical pathology/laboratory medicine clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$80,171in general payments, 2019–2025

Across 37 payments — averaging $2166.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arkray USA, Inc.$45K
  • Beckman Coulter, Inc.$19K
  • Roche Diagnostics Corporation$10K
  • BD$5K
  • Siemens Medical Solutions USA, Inc.$669
  • Diasorin Inc.$95

What the payments were for

  • Consulting fees$63,67679%
  • Speaking & faculty fees$13,34517%
  • Travel & lodging$2,0053%
  • Food & beverage$1,1441%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arkray USA, Inc.13$45,279
Beckman Coulter, Inc.12$19,453
Roche Diagnostics Corporation3$10,037
BD5$4,638
Siemens Medical Solutions USA, Inc.3$669
Diasorin Inc.1$95

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$80,171 in reported general payments places this provider in the 95th percentile of 27 clinical pathology/laboratory medicine providers in Massachusetts.

See all clinical pathology/laboratory medicine providers in Massachusetts

Medicare billing

Part B allowed, 2024
$17,491
Medicare patients
535
Services billed
908

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other clinical pathology/laboratory medicine in Burlington

See the full list for Massachusetts

Where these figures come from

Is this you, or does something look wrong? →